Please use this identifier to cite or link to this item:
Title: Neuroprotection: A New Therapeutic Approach of Relapsing Remitting Multiple Sclerosis
Author: Espinosa-Parrilla, Juan F.
Pugliese, Marco
Mahy Gehenne, Josette Nicole
Rodríguez Allué, Manuel José
Keywords: Esclerosi múltiple
Multiple sclerosis
Issue Date: 8-Sep-2016
Publisher: IntechOpen
Abstract: Neurodegenerative changes occurring early from primary acute immune-mediated inflammation support the hypothesis that multiple sclerosis (MS) is a complex disease. Axonal loss progresses with the disease course and represents the principal driver of disability. In this context, the pursuit of neuroprotective therapies in multiple sclerosis provides new valid alternatives that could significantly impact on disease progression and neurodegenerative changes, including the promotion of restoration of myelin sheaths through the remyelination process. This chapter reviews promising drugs with proposed neuroprotective or neuroregenerative effects that are currently approved or in clinical trials for the treatment of multiple sclerosis. Although the chapter highlights the diazoxide action on neuroinflammation and the results of a clinical trial with this drug, the review also includes other molecules with oral or parenteral administration.
Note: Reprodució del document publicat a:
It is part of: Chapter 13 in: Gonzalez-Quevedo, Alina. 2016. Trending Topics in Multiple Sclerosis. IntechOpen. ISBN: 978-953-51-7310-6. DOI: 10.5772/61417. pp: 307-328.
Related resource:
Appears in Collections:Llibres / Capítols de llibre (Biomedicina)

Files in This Item:
File Description SizeFormat 
297080.pdf2.74 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons